Company intelligence
Milestone Gyno-mics
A new era of women's health
About Milestone Gyno-mics
Milestone Gynomics is an early stage startup ushering in a new era of women’s health. We are developing a non-invasive blood test for accurately diagnosing endometriosis, a devastating disease that causes chronic pain, infertility, and long-term health issues. Despite affecting 1 in 10 women worldwide, it still takes an average of 10 years to reach a diagnosis because the only way to do so is through surgery. Our AI-driven technology analyzes genetic, immune, and microbial signals in the blood to detect unique signatures that enable an accurate diagnosis, providing earlier opportunities to treat pain, reverse infertility, and improve long-term outcomes.
Verified activity
Signals from Milestone Gyno-mics
1 published signal